Retout S[Author] - Search Results

Year	Number of Results
2001	1
2002	2
2003	3
2007	3
2008	1
2009	5
2010	1
2011	1
2013	2
2014	1
2017	2
2018	2
2020	2
2021	2
2022	3
2023	1
2024	1

1

A phase III randomized trial of gantenerumab in prodromal Alzheimer's disease.

Ostrowitzki S, Lasser RA, Dorflinger E, Scheltens P, Barkhof F, Nikolcheva T, Ashford E, Retout S, Hofmann C, Delmar P, Klein G, Andjelkovic M, Dubois B, Boada M, Blennow K, Santarelli L, Fontoura P; SCarlet RoAD Investigators. Ostrowitzki S, et al. Among authors: retout s. Alzheimers Res Ther. 2017 Dec 8;9(1):95. doi: 10.1186/s13195-017-0318-y. Alzheimers Res Ther. 2017. PMID: 29221491 Free PMC article. Clinical Trial.

2

Clinical pharmacology of emicizumab for the treatment of hemophilia A.

Yoneyama K, Schmitt C, Portron A, Kiialainen A, Kotani N, Jaminion F, Retout S, Adamkewicz JI. Yoneyama K, et al. Among authors: retout s. Expert Rev Clin Pharmacol. 2023 Jul-Dec;16(9):775-790. doi: 10.1080/17512433.2023.2243213. Epub 2023 Aug 21. Expert Rev Clin Pharmacol. 2023. PMID: 37529848 Review.

3

Pharmacokinetics, safety, and simulated efficacy of an influenza treatment, baloxavir marboxil, in Chinese individuals.

Liu Y, Retout S, Duval V, Jia J, Zou Y, Wang Y, Cosson V, Jolivet S, De Buck S. Liu Y, et al. Among authors: retout s. Clin Transl Sci. 2022 May;15(5):1196-1203. doi: 10.1111/cts.13237. Epub 2022 Feb 19. Clin Transl Sci. 2022. PMID: 35176206 Free PMC article. Clinical Trial.

4

Disease Modeling and Model-Based Meta-Analyses to Define a New Direction for a Phase III Program of Gantenerumab in Alzheimer's Disease.

Retout S, Gieschke R, Serafin D, Weber C, Frey N, Hofmann C. Retout S, et al. Clin Pharmacol Ther. 2022 Apr;111(4):857-866. doi: 10.1002/cpt.2535. Epub 2022 Feb 28. Clin Pharmacol Ther. 2022. PMID: 35100444 Free PMC article.

5

A Pharmacokinetics-Time to Alleviation of Symptoms Model to Support Extrapolation of Baloxavir Marboxil Clinical Efficacy in Different Ethnic Groups with Influenza A or B.

Retout S, De Buck S, Jolivet S, Duval V, Cosson V. Retout S, et al. Clin Pharmacol Ther. 2022 Aug;112(2):372-381. doi: 10.1002/cpt.2648. Epub 2022 Jun 10. Clin Pharmacol Ther. 2022. PMID: 35585696

6

cLRT-Mod: An efficient methodology for pharmacometric model-based analysis of longitudinal phase II dose finding studies under model uncertainty.

Buatois S, Ueckert S, Frey N, Retout S, Mentré F. Buatois S, et al. Among authors: retout s. Stat Med. 2021 May 10;40(10):2435-2451. doi: 10.1002/sim.8913. Epub 2021 Mar 2. Stat Med. 2021. PMID: 33650148

7

Exposure-Bleeding Count Modeling of Emicizumab for the Prophylaxis of Bleeding in Persons with Hemophilia A with/Without Inhibitors Against Factor VIII.

Jonsson F, Schmitt C, Petry C, Mercier F, Frey N, Retout S. Jonsson F, et al. Among authors: retout s. Clin Pharmacokinet. 2021 Jul;60(7):931-941. doi: 10.1007/s40262-021-01006-0. Epub 2021 Mar 12. Clin Pharmacokinet. 2021. PMID: 33709296 Free PMC article.

8

Population Pharmacokinetic Analysis and Exploratory Exposure-Bleeding Rate Relationship of Emicizumab in Adult and Pediatric Persons with Hemophilia A.

Retout S, Schmitt C, Petry C, Mercier F, Frey N. Retout S, et al. Clin Pharmacokinet. 2020 Dec;59(12):1611-1625. doi: 10.1007/s40262-020-00904-z. Clin Pharmacokinet. 2020. PMID: 32504271 Free PMC article.

9

Population Pharmacokinetics and Exposure-Response Relationships of Baloxavir Marboxil in Influenza Patients at High Risk of Complications.

Koshimichi H, Retout S, Cosson V, Duval V, De Buck S, Tsuda Y, Ishibashi T, Wajima T. Koshimichi H, et al. Among authors: retout s. Antimicrob Agents Chemother. 2020 Jun 23;64(7):e00119-20. doi: 10.1128/AAC.00119-20. Print 2020 Jun 23. Antimicrob Agents Chemother. 2020. PMID: 32312784 Free PMC article.

10

Correction to: A phase III randomized trial of gantenerumab in prodromal Alzheimer's disease.

Ostrowitzki S, Lasser RA, Dorflinger E, Scheltens P, Barkhof F, Nikolcheva T, Ashford E, Retout S, Hofmann C, Delmar P, Klein G, Andjelkovic M, Dubois B, Boada M, Blennow K, Santarelli L, Fontoura P; SCarlet RoAD Investigators. Ostrowitzki S, et al. Among authors: retout s. Alzheimers Res Ther. 2018 Sep 27;10(1):99. doi: 10.1186/s13195-018-0409-4. Alzheimers Res Ther. 2018. PMID: 30261916 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

32 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Results by year